GL1X · GenesisL1 explorer

Research workbench

Crystal structure of clade A/E 93TH057 HIV-1 GP120 core in complex with aws-I-50

Analyse Crystal structure of clade A/E 93TH057 HIV-1 GP120 core in complex with aws-I-50 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4DKP
Type
protein
Length
678 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Clade A/E 93TH057 HIV-1 GP120 core
Ligands
0LL, NAG
Pockets
9 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 17% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CClade A/E 93TH057 HIV-1 GP120 coreprotein33917% helix, 38% strand—

Ligands and binding sites

  • 0LL · N-[(1S,2S)-2-amino-2,3-dihydro-1H-inden-1-yl]-N'-(4-chloro-3-fluorophenyl)ethanediamide · ligand · 2 copies · chains A, C
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 22 copies · chains A, C
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · 2 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18150.780.82100NAG
2780.590.88190LL
3840.580.87200LL
4720.560.8718NAG
5620.460.8318empty

Interfaces

1 interface between chains.

  • A–C · 481 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 22 glycan, 14 disulfide (N-glycosylation, disulfide).

Compared structures

  • 4DKP · Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with AWS-I-50 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.